97 related articles for article (PubMed ID: 1906118)
21. Effect of rosiglitazone on N-nitroso-N-methylurea-induced mammary tumors in rat.
Núñez M; Martín G; Cocca C; Mohamad N; Gutiérrez A; Cricco G; Medina V; Rivera E; Croci M; Crescenti E; Bergoc R
Anticancer Res; 2006; 26(3A):2113-22. PubMed ID: 16827153
[TBL] [Abstract][Full Text] [Related]
22. [Cumulative effects of lentinan and endocrine therapy on the growth of DMBA-induced mammary tumor in rats].
Kosaka A; Imaizumi A; Hatori Y; Mori F; Wani T; Yamashita A
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1399-407. PubMed ID: 6430243
[TBL] [Abstract][Full Text] [Related]
23. [Combined therapies with medroxyprogesterone acetate (MPA) in DMBA-induced rat mammary cancer].
Ishikawa H; Iino Y; Izuo M; Takikawa H
Gan No Rinsho; 1986 Feb; 32(2):151-5. PubMed ID: 2937941
[TBL] [Abstract][Full Text] [Related]
24. Suppression of mammary gland carcinogenesis by post-initiation treatment of rats with tamoxifen or indole-3-carbinol or their combination.
Malejka-Giganti D; Parkin DR; Bennett KK; Lu Y; Decker RW; Niehans GA; Bliss RL
Eur J Cancer Prev; 2007 Apr; 16(2):130-41. PubMed ID: 17297389
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of the antitumor effect of tamoxifen by combination with the antiprogestin onapristone.
Nishino T; Ishibashi K; Hirtreiter C; Nishino Y
J Steroid Biochem Mol Biol; 2009 Sep; 116(3-5):187-90. PubMed ID: 19500671
[TBL] [Abstract][Full Text] [Related]
26. Soluble low-molecular-mass tumor-associated antigens promote the suppression of rat mammary tumors by tamoxifen and prevent its toxic effect.
Ben-Hur H; Kossoy G; Zusman I
Int J Oncol; 2002 Feb; 20(2):413-7. PubMed ID: 11788910
[TBL] [Abstract][Full Text] [Related]
27. Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.
Bischoff ED; Gottardis MM; Moon TE; Heyman RA; Lamph WW
Cancer Res; 1998 Feb; 58(3):479-84. PubMed ID: 9458093
[TBL] [Abstract][Full Text] [Related]
28. [Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA].
Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
Gan To Kagaku Ryoho; 1996 Mar; 23(4):447-54. PubMed ID: 8678496
[TBL] [Abstract][Full Text] [Related]
29. A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Sugamata N; Koibuchi Y; Iino Y; Morishita Y
Int J Oncol; 1999 Feb; 14(2):259-63. PubMed ID: 9917500
[TBL] [Abstract][Full Text] [Related]
30. Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model.
Hilakivi-Clarke L; Wärri A; Bouker KB; Zhang X; Cook KL; Jin L; Zwart A; Nguyen N; Hu R; Cruz MI; de Assis S; Wang X; Xuan J; Wang Y; Wehrenberg B; Clarke R
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27609189
[TBL] [Abstract][Full Text] [Related]
31. Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7,12 dimethylbenz(α)anthracene and decreases cell proliferation: comparison with tamoxifen.
Mansour A; Daba A; Baddour N; El-Saadani M; Aleem E
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1579-96. PubMed ID: 22552717
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin.
Verma AK; Johnson JA; Gould MN; Tanner MA
Cancer Res; 1988 Oct; 48(20):5754-8. PubMed ID: 3139283
[TBL] [Abstract][Full Text] [Related]
33. Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial.
Fargeot P; Bonneterre J; Roché H; Lortholary A; Campone M; Van Praagh I; Monnier A; Namer M; Schraub S; Barats JC; Guastalla JP; Goudier MJ; Chapelle-Marcillac I
J Clin Oncol; 2004 Dec; 22(23):4622-30. PubMed ID: 15505276
[TBL] [Abstract][Full Text] [Related]
34. Induction of tamoxifen-dependent rat mammary tumors.
Zimniski SJ; Warren RC
Cancer Res; 1993 Jul; 53(13):2937-9. PubMed ID: 8319198
[TBL] [Abstract][Full Text] [Related]
35. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
Thun-Battersby S; Mevissen M; Löscher W
Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
[TBL] [Abstract][Full Text] [Related]
36. Dietary fish oil associated with increased apoptosis and modulated expression of Bax and Bcl-2 during 7,12-dimethylbenz(alpha)anthracene-induced mammary carcinogenesis in rats.
Manna S; Chakraborty T; Ghosh B; Chatterjee M; Panda A; Srivastava S; Rana A; Chatterjee M
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):5-14. PubMed ID: 18614344
[TBL] [Abstract][Full Text] [Related]
37. Change in chemosensitivity of DMBA-induced rat mammary tumor after oophorectomy.
Isogai M; Kondo K; Kitamura N
Anticancer Res; 1998; 18(2A):963-6. PubMed ID: 9615747
[TBL] [Abstract][Full Text] [Related]
38. Promoting effect of snuff in rats initiated by 4-nitroquinoline-N-oxide or 7,12-dimethylbenz(a)anthracene.
Johansson SL; Saidi J; Osterdahl BG; Smith RA
Cancer Res; 1991 Aug; 51(16):4388-94. PubMed ID: 1907884
[TBL] [Abstract][Full Text] [Related]
39. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
Iino Y; Karakida T; Sugamata N; Andoh T; Takei H; Takahashi M; Yaguchi S; Matsuno T; Takehara M; Sakato M; Kawashima S; Morishita Y
Anticancer Res; 1998; 18(1A):171-6. PubMed ID: 9568073
[TBL] [Abstract][Full Text] [Related]
40. [Effect of direct current therapy with chemotherapy in 7,12-dimethylbenz[alpha] anthracene (DMBA)-induced rat mammary cancer].
Yokota T
Nihon Geka Gakkai Zasshi; 1995 Oct; 96(10):703-8. PubMed ID: 8538589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
